Controlled Release of Topical Nitric Oxide for Treating Cutaneous Injuries

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$780,029.00
Award Year:
2012
Program:
SBIR
Phase:
Phase II
Contract:
W81XWH-11-C-0031
Award Id:
n/a
Agency Tracking Number:
A2-4861
Solicitation Year:
2010
Solicitation Topic Code:
A10-160
Solicitation Number:
2010.3
Small Business Information
26 Ashlawn Circle, Malvern, PA, -
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
832603067
Principal Investigator:
JohnAybar
CEO
(610) 517-1878
aybarc@gmail.com
Business Contact:
JohnAybar
CEO
(610) 517-7818
aybarc@gmail.com
Research Institute:
Stub




Abstract
In this proposal Zeomedix proposes to develop a dressing for infected trauma wounds based on its zeolite encapsulating nitric oxide (NO) technology. Nitric oxide has been shown to enhance the wound healing process as well as act as a powerful antibacterial agent. However, delivery of nitric oxide to a wound area is extremely challenging because NO is a gas. Zeomedixs approach is to use zeolites that bind NO molecules when exposed to a stream of gaseous NO. When NO-loaded zeolites come in contact with water (or wound fluid), NO is released into the wound area. The overall goal of Zeomedixs Phase II project is to develop an optimal NO-zeolite wound dressing for treating infected acute wounds. Our technical approach can be organized into three steps: (1) Develop three different NO-zeolite wound dressing prototypes, consisting of NO-zeolite ointment enclosed within a semi-porous pouch, each having distinct nitric oxide release rates. (2) Characterize the storage stability, cytotoxicity, and antimicrobial efficacy of the prototypes against both planktonic microorganisms and bacterial biofilms in vitro. (3) Evaluate the ability of the two leading prototypes to reduce wound infection and improve wound healing in vivo using a full-thickness infected porcine wound model. The overall goal of Zeomedixf"ff3/4s Phase II project is to develop an optimal NO-zeolite wound dressing for treating infected acute wounds. Our technical approach can be organized into three steps: (1) Develop three different NO-zeolite wound dressing prototypes, consisting of NO-zeolite ointment enclosed within a semi-porous pouch, each having distinct nitric oxide release rates (2) Characterize the storage stability, cytotoxicity, and antimicrobial efficacy of the prototypes against both planktonic microorganisms and bacterial biofilms in vitro (3) Evaluate the ability of the two leading prototypes to reduce wound infection and improve wound healing in vivo using a full-thickness infected porcine wound model

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government